These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12799292)

  • 1. Biology and plasticity of CD133+ hematopoietic stem cells.
    Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
    Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
    Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
    Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
    Kuçi S; Wessels JT; Bühring HJ; Schilbach K; Schumm M; Seitz G; Löffler J; Bader P; Schlegel PG; Niethammer D; Handgretinger R
    Blood; 2003 Feb; 101(3):869-76. PubMed ID: 12393715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient mice.
    Brenner S; Ryser MF; Whiting-Theobald NL; Gentsch M; Linton GF; Malech HL
    Stem Cells; 2007 Jul; 25(7):1807-13. PubMed ID: 17464090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo culture of human cord blood hematopoietic stem/progenitor cells adversely influences their distribution to other bone marrow compartments after intra-bone marrow transplantation.
    Yamamura K; Ohishi K; Masuya M; Miyata E; Sugimoto Y; Nakamura S; Fujieda A; Araki H; Katayama N
    Stem Cells; 2008 Feb; 26(2):543-9. PubMed ID: 17975223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.
    Radtke S; Haworth KG; Kiem HP
    Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7.
    Gallacher L; Murdoch B; Wu DM; Karanu FN; Keeney M; Bhatia M
    Blood; 2000 May; 95(9):2813-20. PubMed ID: 10779426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.
    Quirici N; Soligo D; Caneva L; Servida F; Bossolasco P; Deliliers GL
    Br J Haematol; 2001 Oct; 115(1):186-94. PubMed ID: 11722432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
    Pirson L; Baron F; Meuris N; Giet O; Castermans E; Greimers R; Di Stefano I; Gothot A; Beguin Y
    Stem Cells; 2006 Jul; 24(7):1814-21. PubMed ID: 16614006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD34(lo)CD133(lo) fetal liver cells support the expansion of human CD34(hi)CD133(hi) hematopoietic stem cells.
    Yong KS; Keng CT; Tan SQ; Loh E; Chang KT; Tan TC; Hong W; Chen Q
    Cell Mol Immunol; 2016 Sep; 13(5):605-14. PubMed ID: 27593483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.